4//SEC Filing
Sussman Norman 4
Accession 0001209191-23-012114
CIK 0001082038other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 1:23 PM ET
Size
7.7 KB
Accession
0001209191-23-012114
Insider Transaction Report
Form 4
DURECT CORPDRRX
Sussman Norman
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-21+24,557→ 24,557 totalExercise: $5.07Exp: 2033-02-21→ Common Stock (24,557 underlying) - Award
Stock Option (right to buy)
2023-02-21+45,000→ 45,000 totalExercise: $5.07Exp: 2033-02-21→ Common Stock (45,000 underlying)
Footnotes (2)
- [F1]The option will vest and become exercisable in installments of one-sixteenth (1/16) of the total number of shares at the end of each three month period following the grant date, subject to the Reporting Person providing continuous service to the Issuer through the applicable vesting date.
- [F2]The option is fully vested and immediately exercisable.
Documents
Issuer
DURECT CORP
CIK 0001082038
Entity typeother
Related Parties
1- filerCIK 0001358508
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 1:23 PM ET
- Size
- 7.7 KB